Avoro Capital Advisors LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$5.7T
Holdings
30
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA | 4,980,000 | $859.5B | 15.05% | |
| 2 | UTHUNITED THERAPEUTICS CORP | 2,370,000 | $681.0B | 11.93% | |
| 3 | ARGXARGENX SE | 1,175,000 | $647.7B | 11.34% | |
| 4 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,875,000 | $567.5B | 9.94% | |
| 5 | KRYSKRYSTAL BIOTECH INC | 2,660,000 | $365.6B | 6.40% | |
| 6 | KYMRKYMERA THERAPEUTICS INC | 6,555,555 | $286.1B | 5.01% | |
| 7 | APLSAPELLIS PHARMACEUTICALS INC. | 12,222,222 | $211.6B | 3.71% | |
| 8 | RNAAVIDITY BIOSCIENCES INC | 7,050,000 | $200.2B | 3.51% | |
| 9 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 4,150,000 | $195.9B | 3.43% | |
| 10 | AKROAKERO THERAPEUTICS INC | 3,500,000 | $186.8B | 3.27% | |
| 11 | SLNOSOLENO THERAPEUTICS INC | 2,050,000 | $171.7B | 3.01% | |
| 12 | XENEXENON PHARMACEUTICALS INC | 5,400,000 | $169.0B | 2.96% | |
| 13 | ARWRARROWHEAD PHARMACEUTICALS INC. | 10,600,000 | $167.5B | 2.93% | |
| 14 | MRUSMERUS N V | 3,155,555 | $166.0B | 2.91% | |
| 15 | VERAVERA THERAPEUTICS INC | 6,300,000 | $148.4B | 2.60% | |
| 16 | AM6AMICUS THERAPEUTICS INC. | 18,000,000 | $103.1B | 1.81% | |
| 17 | ALKSALKERMES PLC | 2,900,000 | $83.0B | 1.45% | |
| 18 | OCULOCULAR THERAPEUTIX INC | 7,400,000 | $68.7B | 1.20% | |
| 19 | ETNBGBP89BIO INC | 6,750,000 | $66.3B | 1.16% | |
| 20 | CNTACENTESSA PHARMACEUTICALS PLC | 5,000,000 | $65.7B | 1.15% | |
| 21 | QUREUNIQURE NV | 3,625,000 | $50.5B | 0.88% | |
| 22 | TSHATAYSHA GENE THERAPIES INC | 21,700,000 | $50.1B | 0.88% | |
| 23 | 2L9BLUEPRINT MEDICINES CORP | 375,000 | $48.1B | 0.84% | |
| 24 | TRMLTOURMALINE BIO INC | 2,555,555 | $40.9B | 0.72% | |
| 25 | BCRXBIOCRYST PHARMACEUTICALS INC | 4,500,000 | $40.3B | 0.71% | |
| 26 | MNKDMANNKIND CORP | 5,850,000 | $21.9B | 0.38% | |
| 27 | GLUEMONTE ROSA THERAPEUTICS INC | 3,725,000 | $16.8B | 0.29% | |
| 28 | SEPNSEPTERNA INC | 1,237,500 | $13.1B | 0.23% | |
| 29 | RAREULTRAGENYX PHARMACEUTICAL INC | 330,000 | $12.0B | 0.21% | |
| 30 | WHWKWHITEHAWK THERAPEUTICS INC | 2,849,402 | $5.3B | 0.09% |